University of Kansas Cancer Center

Our 麻豆传媒 on 麻豆传媒
View All >

KU Cancer Center researcher identifies triple-negative breast cancer biomarker

Triple-negative breast cancer is a highly aggressive subtype of breast cancer that affects 10% - 15% of all breast cancer patients. According to the American Cancer Society, Black women are more than twice as likely as other ethnic populations to...
30-Apr-2025 12:15 PM EDT Add to Favorites

麻豆传媒: 67c870b47b33e_BossmannStefanCancerBiology20201.jpg

Stefan Bossmann Selected as Senior Member of the National Academy of Inventors

Stefan Bossmann, Ph.D., professor and chair of the Department of Cancer Biology at the University of Kansas Medical Center, was selected by the National Academy of Inventors (NAI) to join the 2025 class of senior members. He is the first senior...
5-Mar-2025 10:40 AM EST Add to Favorites

KU-Led Multicenter Trial to Address Food Insecurity and Malnutrition in Cancer Patients

Researchers are leading a multicenter trial, funded by a five-year, nearly $4 million grant awarded last fall by the National Institutes of Health, to tackle food insecurity in people with blood cancers who are receiving transplant or cellular...
13-Jan-2025 2:55 PM EST Add to Favorites

KU Medical Center Evaluating Smoking-Cessation Interventions for Black Adults in a Five-State Study

The University of Kansas Medical Center is partnering with the University of Wisconsin Center for Tobacco Research and Intervention to determine what treatments work best to help Black people to quit smoking. Their research is funded with a $10...
9-Dec-2024 2:55 PM EST Add to Favorites

Traumatic Childhood Events May Increase Risk for Long-Term Health Effects in Breast Cancer Survivors

Childhood trauma can increase a breast cancer survivor鈥檚 chance of experiencing more severe and longer-lasting treatment-related anxiety, depression and fatigue, as well as reduced cognitive function, years after cancer treatment has ended,...
12-Nov-2024 3:50 PM EST Add to Favorites

KU Cancer Center Leads National Trial Testing Vaccine for Colon Cancer in People with Lynch Syndrome

A researcher at The University of Kansas Cancer Center is leading a national clinical trial to test a combination vaccine to prevent colon cancer in people with Lynch syndrome.
23-Oct-2024 2:35 PM EDT Add to Favorites

Study Finds Opt-Out Treatment Helps Smokers Quit, Even Those with Low Motivation

Study Finds Opt-Out Treatment Helps Smokers Quit, Even Those with Low Motivation
18-Oct-2024 12:25 PM EDT Add to Favorites

A Precision-Medicine Initiative Sponsored by the National Cancer Institute Aims to Improve Treatment for the Most Common Form of Leukemia in Adults

The University of Kansas Cancer Center is part of the myeloMATCH trial, a large, coordinated effort to improve patient outcomes through targeted treatments for people with acute myeloid leukemia or myelodysplastic syndrome.
23-Sep-2024 2:05 PM EDT Add to Favorites

See All News

Our Experts on News

VIDEO

Triple-Threat

Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT

Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing 麻豆传媒. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT

Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

See All Experts

Our YouTube Videos
View All >

About

The University of Kansas Cancer Center is a world-class, community-based, NCI-designated comprehensive cancer research and care partnership spanning two states and involving collaboration among researchers, physicians and cancer support professionals. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and health care professionals associated with the University of Kansas Medical Center and The University of Kansas Health System in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, The Stowers Institute for Medical Research, Children's Mercy and members of the Masonic Cancer Alliance.